Mosaicism due to myeloid lineage-restricted loss of heterozygosity as cause of spontaneous Rh phenotype splitting

Blood

Volumn 110, Issue 6, 2007, Pages 2148-2157

  Körmöczi, Günther F ^a   Dauber, Eva Maria ^a   Haas, Oskar A ^b   Legler, Tobias J ^c   Clausen, Frederik B ^c   Fritsch, Gerhard ^b   Raderer, Markus ^a   Buchta, Christoph ^a   Petzer, Andreas L ^d   Schönitzer, Diether ^d   Mayr, Wolfgang R ^a   Gassner, Christoph ^d  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b CHILDREN'S CANCER RESEARCH INSTITUTE   (Austria)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD CELL; BLOOD GROUP RHESUS SYSTEM; CELL SORTER; CHIMERA; CHROMOSOME 1; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; GENE LOCUS; HEMATOLOGIC DISEASE; HEMATOPOIETIC CELL; HETEROZYGOSITY; HUMAN; MALE; MOSAICISM; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STEM CELL TRANSPLANTATION;

EID: 34548816442     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2007-01-068106     Document Type: Article

References (52)

1. Avent ND, Reid ME. The Rh blood group system: a review. Blood. 2000;95:375-387.
2. Daniels G. Human blood groups. 2nd ed. Oxford, United Kingdom: Blackwell Science; 2002.
3. Wagner FF, Flegel WA. RHD gene deletion occurred in the rhesus box. Blood. 2000;95:3662-3668.
4. Tippett P. Blood group chimeras: a review. Vox Sang. 1983;44:333-359.
5. van Dijk BA, Boomsma DI, de Man AJM. Blood group chimerism in human multiple births is not rare. Am J Med Genet. 1996;61:264-268.
6. Bird GW, Wingham J, Nicholson GS, Battey DA, Koster HG, Webb T. Another example of haemopoietic (twin) chimaerism in a subject unaware of being a twin. J Immunogenet. 1982;9:317-322.
7. Cherif-Zahar B, Bony V, Steffensen R, et al. Shift from Rh-positive to Rh-negative phenotype caused by a somatic mutation within the RHD gene in a patient with chronic myelocytic leukaemia. Br J Haematol. 1998;102:1263-1270.
8. Miyoshi O, Yabe R, Wakui K, et al. Two cases of mosaic RhD blood-group phenotypes and paternal isodisomy for chromosome 1. Am J Med Genet. 2001;104:250-256.
9. Majsky A. Some cases of leukaemia with modifications of the D(Rho)-receptor. Neoplasma. 1967;14:335-344.
10. Cooper B, Tishler PV, Atkins L, Breg WR. Loss of Rh antigen associated with acquired Rh antibodies and a chromosome translocation in a patient with myeloid metaplasia. Blood. 1979;54:642-647.
11. Callender ST, Kay HE, Lawler SD, Millard RE, Sanger R, Tippett PA. Two populations of Rh groups together with chromosomally abnormal cell lines in the bone marrow. Br Med J. 1971;1:131-133.
12. Habibi B, Lopez M, Salmon C. Two new cases of Rh mosaicism: selective study of red cell populations. Vox Sang. 1974;27:232-242.
13. Bracey AW, McGinniss MH, Levine RM, Whang-Peng J. Rh mosaicism and aberrant MNSs antigen expression in a patient with chronic myelogenous leukemia. Am J Clin Pathol. 1983;79:397-401.
14. Mohandas K, Najfield V, Gilbert H, Azar P, Skerrett D. Loss and reappearance of Rho(D) antigen on the red blood cells of an individual with acute myelogenous leukemia. Immunohematol. 1994;10:134-135.
15. Winters JL, Howard DS. Red blood cell antigen changes in malignancy: case report and review. Immunohematol. 2001;17:1-9.
16. Northoff H, Goldmann SF, Lattke H, Steinbach P. A patient, mosaic for Rh and Fy antigens lacking other signs of chimerism or chromosomal disorder. Vox Sang. 1984;47:164-169.
17. Salaru NNR, Lay WH. Rh blood group mosaicism in a healthy elderly woman. Vox Sang. 1985;48:362-365.
18. Flegel WA. How I manage donors and patients with a weak D phenotype. Curr Opin Hematol. 2006;13:476-483.
19. Wagner F, Frohmajer A, Flegel W. RHD positive haplotypes in D negative europeans. BMC Genet. (http://www.biomedcentral.com/content/pdf/1471-2156-2-10. pdf). July 16, 2001;2:10. Accessed December 27, 2006.
20. Körmöczi GF, Legler TJ, Daniels GL, et al. Molecular and serologic characterization of DWI, a novel "high-grade" partial D. Transfusion. 2004;44:575-580.
21. Körmöczi GF, Förstemann E, Gabriel C, Mayr WR, Schönitzer D, Gassner C. Novel weak D types 31 and 32: adsorption/elution- supported D antigen analysis and comparison to prevalent weak D types. Transfusion. 2005;45:1574-1580.
22. Wagner T, Körmöczi GF, Buchta C, et al. Anti-D immunization by DEL red blood cells. Transfusion. 2005;45:520-526.
23. Körmöczi GF, Gassner C, Shao CP, Uchikawa M, Legler TJ. A comprehensive analysis of DEL types: partial DEL individuals are prone to anti-D alloimmunization. Transfusion. 2005;45:1561-1567.
24. Fritsch G, Witt V, Dubovsky J, et al. Flow cytometric monitoring of hematopoietic reconstitution in myeloablated patients following allogeneic transplantation. Cytotherapy. 1999;1:295-309.
25. Petzer AL, Gunsilius E, Zech N, et al. Evaluation of optimal survival of primitive progenitor cells (LTC-IC) from PBPC apheresis products after overnight storage. Bone Marrow Transplant. 2000;25:197-200.
26. Coulombel L, Eaves AC, Eaves CJ. Enzymatic treatment of long-term human marrow cultures reveals the preferential location of primitive hemopoietic progenitors in the adherent layer. Blood. 1983;62:291-297.
27. Walsh PS, Metzger DA, Higuchi R. Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques. 1991;10:506-513.
28. Gassner C, Kraus RL, Dovc T, et al. Fyx is associated with two missense point mutations in its gene and can be detected by PCR-SSP. Immunohematol. 2000;16:61-67.
29. Legler TJ, Lynen R, Maas JH, et al. Prediction of fetal Rh D and Rh CcEe phenotype from maternal plasma with real-time polymerase chain reaction. Transfus Sci. 2002;27:217-223.
30. Lo YM, Tein MS, Lau TK, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet. 1998;62:768-775.
31. Legler TJ, Liu Z, Mavrou A, et al. Workshop report on the extraction of fetal DNA from maternal plasma. Prenatal Diag. Prepublished on June 29, 2007, as DOI 10.1002/pd.1783.
32. Gassner C, Schmarda A, Kilga-Nogler S, et al. RHD/CE typing by polymerase chain reaction using sequence-specific primers. Transfusion. 1997;37:1020-1026.
33. Rozman P, Dovc T, Gassner C. Differentiation of autologous ABO, RHD, RHCE, KEL, JK, and FY blood group genotypes by analysis of peripheral blood samples of patients who have recently received multiple transfusions. Transfusion. 2000;40:936-942.
34. König M, Reichel M, Marschalek R, Haas OA, Strehl S. A highly specific and sensitive fluorescence in situ hybridization assay for the detection of t(4;11)(q21;q23) and concurrent submicroscopic deletions in acute leukaemias. Br J Haematol. 2002;116:758-764.
35. Scott M. Section 1A: Rh serology coordinator's report. Transfus Clin Biol. 2002;9:23-29.
36. Pogo AO, Chaudhuri A. The Duffy protein: a malarial and chemokine receptor. Semin Hematol. 2000;37:122-129.
37. Mouro-Chanteloup I, D'Ambrosio AM, Gane P, et al. Cell-surface expression of RhD blood group polypeptide is posttranscriptionally regulated by the RhAG glycoprotein. Blood. 2002;100:1038-1047.
38. Drexler C, Wagner T. Blood group chimerism. Curr Opin Hematol. 2006;13:484-489.
39. Drexler C, Glock B, Vadon M, et al. Tetragametic chimerism detected in a healthy woman with mixed-field agglutination reactions in ABO blood grouping. Transfusion. 2005;45:698-703.
40. UniSTS. Summary of Maps in UniSTS. Available at: http://www.ncbi.nlm.nih. gov/entrez/query. fcgi?db=unists. Accessed on December 27, 2006.
41. Wang L, Ogawa S, Hangaishi A, et al. Molecular characterization of the recurrent unbalanced translocation der(1;7)(q10;p10). Blood. 2003;102:2597-2604.
42. Sanada M, Uike N, Ohyashiki K, et al. Unbalanced translocation der(1;7)(q10;p10) defines a unique clinicopathological subgroup of myeloid neoplasms. Leukemia. 2007;21:992-997.
43. Raghavan M, Lillington DM, Skoulakis S, et al. Genome-wide single nucleotide polymorphism analysis reveals frequent partial uniparental disomy due to somatic recombination in acute myeloid leukemias. Cancer Res. 2005;65:375-378.
44. Fitzgibbon J, Smith LL, Raghavan M, et al. Association between acquired uniparental disomy and homozygous gene mutation in acute myeloid leukemias. Cancer Res. 2005;65:9152-9154.
45. Hermand P, Gane P, Mattei MG, Sistonen P, Cartron JP, Bailly P. Molecular basis and expression of the LWa/LWb blood group polymorphism. Blood. 1995;86:1590-1594.
46. Boklage CE. Embryogenesis of chimeras, twins and anterior midline asymmetries. Hum Reprod. 2006;21:579-591.
47. de Nooij-van Dalen AG, van Buuren-van Seggelen VH, Lohman PH, Giphart-Gassler M. Chromosome loss with concomitant duplication and recombination both contribute most to loss of heterozygosity in vitro. Genes Chromosomes Cancer. 1998;21:30-38.
48. de Nooij-van Dalen AG, Morolli B, van der Keur M, van der Marel A, Lohman PH, Giphart-Gassler M. Intrinsic genetic instability of normal human lymphocytes and its implication for loss of heterozygosity. Genes Chromosomes Cancer. 2001;30:323-335.
49. Jenkins WJ, Marsh WL. Somatic mutation affecting the Rhesus and Duffy blood group system. Transfusion. 1965;5:6-10.
50. Bianco T, Farmer BJ, Sage RE, Dobrovic A. Loss of red cell A, B, and H antigens is frequent in myeloid malignancies. Blood. 2001;97:3633-3639.
51. Mertens G, Gielis M, Muylle L, de Raedt S. Loss of D and C expression in chronic myelomonocytic leukemia. Transfusion. 1997;37:880-881.
52. Hofmann WK, Takeuchi S, Xie D, Miller CW, Hoelzer D, Koeffler HP. Frequent loss of heterozygosity in the region of D1S450 at 1p36.2 in myelodysplastic syndromes. Leuk Res. 2001;25:855-858.